Homocysteine and Folate Deficiency Sensitize Oligodendrocytes to the Cell Death-Promoting Effects of a Presenilin-1 Mutation and Amyloid β-Peptide
Abstract
Although damage to white matter occurs in the brains of patients with Alzheimer's disease (AD), the underlying mechanisms are unknown. Recent findings suggest that individuals with elevated levels of homocysteine are at increased risk of AD. Here we show that oligodendrocytes from mice expressing a mutant form of presenilin-1 (PS1) that causes familial AD exhibit increased sensitivity to death induced by homocysteine compared to oligodendrocytes from wild-type control mice. Homocysteine also sensitized oligodendrocytes to the cytotoxicity of amyloid beta-peptide. Folate deficiency, which is known to result in elevated levels of homocysteine in vivo, also sensitized oligodendrocytes to the cell-death-promoting actions of mutant PS1 and amyloid beta-peptide. Inhibitors of poly (ADP-ribose) polymerase and p53 protected oligodendrocytes against cell death induced by homocysteine and amyloid beta-peptide, consistent with a role for a DNA-damage response in the cell death process. These findings demonstrate an adverse effect of homocysteine on oligodendrocytes, and suggest roles for homocysteine and folate deficiency in the white matter damage in AD and related neurodegenerative disorders.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MTX targets folate synthesis.
“One commonly suspected chemotherapy agent is MTX, which targets folate synthesis (Graham et al., 1992; Pak, Chan, & Mattson, 2003).”
From Brain structure, working memory and response inhibition in childhood leukemia survivors (2017) · cites this paper as Pak, Chan, & Mattson, 2003
The citation lists haven’t been fetched yet
References 47 · Cited by 26
- Authors
- Pak, K. J., Chan, S. L., & Mattson, M. P.
- Affiliations
- National Institute on Aging (US)
- Corresponding author
- Mattson, Mark P.
- ORCID
- Mattson, Mark P.
- Venue
- NeuroMolecular Medicine
- Published
- 2003
- Volume
- 3
- Issue
- 2
- Pages
- 119-128
- ISSN
- 1535-1084 (ISSN-L)
- OpenAlex
- W2058157182
- Cited by
- 26
- References
- 47
- Citations by year
- 2024: 2 · 2023: 1 · 2017: 1 · 2016: 1 · 2012: 2
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- NeuroMolecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Rheumatology › Folate and B Vitamins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- homocysteine, folate deficiency, oligodendrocytes, presenilin 1 mutations, amyloid-beta, Alzheimer's disease, white matter injury, neuronal cell death, DNA damage response, poly(ADP-ribose) polymerase, p53, familial Alzheimer's disease
- MeSH terms
- Poly(ADP-ribose) Polymerase Inhibitors, Alzheimer Disease, Animals, Brain, Cells, Cultured, Disease Models, Animal, DNA Damage, Enzyme Inhibitors, Folic Acid Deficiency, Homocysteine, Membrane Proteins, Mice, Mutant Strains, Mutation, Nerve Fibers, Myelinated, Oligodendroglia, Poly(ADP-ribose) Polymerases, Up-Regulation, Tumor Suppressor Protein p53, Amyloid beta-Peptides, Cell Death, Mice, Presenilin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review